Formosa Laboratories, Inc.

Taiwan Stock Exchange 4746.TW

Formosa Laboratories, Inc. Market Capitalization on January 14, 2025: USD 262.96 M

Formosa Laboratories, Inc. Market Capitalization is USD 262.96 M on January 14, 2025, a -35.87% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Formosa Laboratories, Inc. 52-week high Market Capitalization is USD 459.29 M on January 26, 2024, which is 74.66% above the current Market Capitalization.
Formosa Laboratories, Inc. 52-week low Market Capitalization is USD 252.71 M on December 27, 2024, which is -3.90% below the current Market Capitalization.
Formosa Laboratories, Inc. average Market Capitalization for the last 52 weeks is USD 362.51 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Taiwan Stock Exchange: 4746.TW

Formosa Laboratories, Inc.

CEO	Dr. Chen-Yu Cheng Ph.D.
IPO Date	Feb. 28, 2011
Location	Taiwan
Headquarters	36 Hoping Street
Employees	867
Sector	Health Care
Industries Pharmaceuticals

Description

Formosa Laboratories, Inc. produces and sells active pharmaceutical ingredients (APIs) worldwide. The company offers APIs in the areas of anticancer, anti-inflammatory and analgesic agents, MRI enhancing agents, cholesterol and phosphate binders, CNS agents, immunomodulators, respiratory agents, steroids, vitamin D derivatives, and antibiotics. It also provides contract development and manufacturing services; solutions for manufacturing antibody-drug conjugates; and injectable manufacturing services. The company was founded in 1995 and is based in Taoyuan City, Taiwan.

Key trends

Past 5 years